SEC Tracker
Get the app

Icon ICLR

Icon reports $2.02B revenue for Q3 2026

Foreign issuer report

Form
6-K
Filed
Importance
Routine
  1. Revenue: $2.02 billion for the three months ended Sep 30, 2026
  2. Net income: $122.13 million for the three months ended Sep 30, 2026
  3. Diluted EPS: $1.58 for the three months ended Sep 30, 2026
  4. Cash and equivalents: $808.98 million at Sep 30, 2026

Written from the 6-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Icon files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 8731 and related industry codes: the same peer list as the financial tables.

  1. Absci ABSI public float $304M, Jun 30, 2025
  2. bioAffinity Technologies BIAF public float $23M, Jun 30, 2025
  3. Weed BUDZ public float $2M, Jun 30, 2025
  4. Cannabis Bioscience International Holdings CBIH
  5. Charles River Laboratories International CRL public float $7.3B, Jun 28, 2025